Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Chikara Okumura"'
Publikováno v:
SAGE Open Medical Case Reports, Vol 2 (2014)
Chronic tophaceous gout is the end stage of gout. We employed a blockade of interleukin-6 signaling therapy by tocilizumab instead of anakinra, an interleukin-1 receptor antagonist, for a 61-year-old Japanese woman diagnosed with tophaceous gout. Lab
Externí odkaz:
https://doaj.org/article/87881ae4a56d47b38e58a74449369b97
Autor:
Haruhiko Osawa, Toshihiro Yamamoto, Mie Kurata, Shinnosuke Morikawa, Tamotsu Zako, Junya Masumoto, Naoe Kaneko, Chikara Okumura, Ayaka Nakanishi, Haruka Taguchi
Publikováno v:
International Journal of Immunopathology and Pharmacology
Recent findings revealed that type 2 diabetes mellitus (T2D) is a chronic inflammatory disease and an islet amyloid polypeptide (IAPP)/amylin, is deposited within pancreatic islets. IAPP/amylin has been reported to activate NACHT, LRR, and PYD domain
Publikováno v:
Nihon rinsho. Japanese journal of clinical medicine. 71(8)
Inflammation is a protective response intended to eliminate primary causes of tissue injury, leading to tissue repair and adaptation in a focal lesion. It is thought that various factors are involved in the histopathological responses to tissue injur
Publikováno v:
SAGE Open Medical Case Reports, Vol 2 (2014)
SAGE Open Medical Case Reports
SAGE Open Medical Case Reports
Chronic tophaceous gout is the end stage of gout. We employed a blockade of interleukin-6 signaling therapy by tocilizumab instead of anakinra, an interleukin-1 receptor antagonist, for a 61-year-old Japanese woman diagnosed with tophaceous gout. Lab